Classified in: HealthSubjects: WOM,
RCL,
PSF,
CFG
Advisory - Duchesnay Inc. recalls certain lots of PregVit and PregVit folic 5 prenatal and postpartum vitamin-mineral supplements because of a packaging error
OTTAWA, Nov. 15, 2019 /CNW/ - Health Canada is advising Canadians that Duchesnay Inc. is recalling certain lots of PregVit vitamin-mineral supplements (for prenatal and postpartum use) and PregVit folic 5 vitamin-mineral supplements (for prenatal use) because blister packages may contain all pink (morning) tablets instead of the correct combination of pink and blue (evening) tablets. The company estimates the issue affects a very small number of products in certain lots (see the table below) and not all products.
There are no quality, safety or effectiveness concerns with the tablets themselves but there is the potential that patients may not take the proper combination of pink and blue tablets if they have received products impacted by the packaging error.
The pink and the blue tablets do not contain the same active ingredients. Women taking all pink tablets will not receive the intended vitamin and mineral supplements. In particular, the pink tablets do not contain folic acid, which is important for the healthy growth of an unborn baby and helps to reduce some types of birth defects called neural tube defects.
Properly packaged products should contain two blister packs, with each blister pack containing 15 pink tablets and 15 blue tablets. The company received a complaint of a product containing a blister pack that contained all pink tablets and no blue tablets.
Who is affected
Women who have bought or are using the affected products.
Affected products
Product
| DIN
| Lot
| Expiry
|
PregVit
Format 60
| 02451573
| 19003
| 2021-10-31
|
19001V
| 2021-09-30
|
18015V
| 2021-08-31
|
18010V
| 2021-05-31
|
18012V
| 2021-04-30
|
18006V
| 2020-08-31
|
18003V
| 2020-06-30
|
17019V
| 2020-05-31
|
17016
| 2020-07-31
|
17002
| 2020-03-31
|
16065
| 2020-02-29
|
16064
| 2020-01-31
|
16045
| 2019-12-31
|
16042
| 2019-12-31
|
PregVit folic 5
Format 60
| 02451581
| 18022
| 2021-07-31
|
18007
| 2020-10-31
|
18002
| 2020-09-30
|
16053
| 2019-12-31
|
What consumers should do
- Check your product to make sure it contains the correct combination of pink and blue tablets (each blister pack should contain 15 pink and 15 blue tablets [see photos]).
- Continue taking the prescribed number of pink and blue tablets per day as directed by your health care professional. If your product has an incorrect tablet combination, talk to your pharmacist about obtaining a replacement. Properly packaged products do not need to be returned.
- Consult your health care professional if you have used either of these products and have health concerns.
- Contact Duchesnay Inc. by calling toll-free at 1-888-666-0611, or by email at medicalinfo@duchesnay.com, if you have any questions about the recall.
- Report any health product adverse events or complaints to Health Canada.
Additional information for pharmacists
- Check packages of PregVit and PregVit folic 5 before dispensing them to patients.
- Not all lots are being recalled. While the company has put a verification process in place to make sure that products not impacted by this recall are properly packaged, checking products before dispensing provides an added safeguard.
What Health Canada is doing
Health Canada is monitoring the recall and verifying that the company has effectively addressed the packaging issue. Should additional safety concerns be identified, Health Canada will take appropriate action and inform Canadians as necessary.
Également disponible en français
SOURCE Health Canada
These press releases may also interest you
at 06:00 |
|
|
Ceribell, Inc announced the launch of Clarity, a new 24/7 bedside EEG monitoring and alerting technology, at the American Epileptology Society Annual Meeting. Ceribell's Rapid Response EEG system made bedside EEG possible for critically ill patients...
|
at 06:00 |
|
|
Intelligent.com, a trusted resource for online degree rankings and higher education planning, has announced the Top 25 Doctorate in Psychology Degree Programs for 2020. The comprehensive research guide is based on an assessment of 148 accredited...
|
at 03:00 |
|
|
On one end of the humility spectrum, there's the braggers. It doesn't matter if all they've done is fry an egg without burning it - the entire world must know of their accomplishments. Next, there's the humble-braggers. They think they're being...
|
at 02:40 |
|
|
Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, announced today that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc. Bermekimab is an...
|
6 déc 2019 |
|
|
BrainCo's prosthetic hand won Time Magazine's Top 100 Inventions of the Year. The prosthetic hand represents an advancement in assistive technology, providing amputees with an intuitively controlled prosthetic at a lower cost. ...
|
6 déc 2019 |
|
|
Helix BioPharma Corp. ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the voting results of the Company's annual and special meeting of...
|
|
|
|
News published on 15 november 2019 at 20:49 and distributed by: